Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine
- PMID: 2686622
- PMCID: PMC1133356
- DOI: 10.1042/bj2620881
Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine
Abstract
The insulin-resistant obese fa/fa rat is a convenient model in which to study a potential effect of metformin, a biguanide used in the treatment of non-insulin-dependent diabetes, on insulin-mediated glucose utilization. Female fa/fa rats were given metformin orally for 8 days. Studies were performed on anaesthetized post-absorptive rats 5 h after the last dose of metformin. Glucose production and utilization were enhanced 1.5-fold in metformin-treated rats. The enhanced glucose production was almost entirely due to increased glucose recycling. The digestive tract was the only tissue responsible for the enhanced glucose utilization.
Similar articles
-
Importance of the intestine as a site of metformin-stimulated glucose utilization.Br J Pharmacol. 1994 Jun;112(2):671-5. doi: 10.1111/j.1476-5381.1994.tb13128.x. Br J Pharmacol. 1994. PMID: 8075887 Free PMC article.
-
In vivo metformin treatment ameliorates insulin resistance: evidence for potentiation of insulin-induced translocation and increased functional activity of glucose transporters in obese (fa/fa) Zucker rat adipocytes.Endocrinology. 1993 Jul;133(1):304-11. doi: 10.1210/endo.133.1.8391425. Endocrinology. 1993. PMID: 8391425
-
Effects of metformin on insulin resistance after injury in the rat.Diabetologia. 1976 Mar;12(1):53-60. doi: 10.1007/BF01221965. Diabetologia. 1976. PMID: 1254116
-
Effect of metformin on glucose metabolism in the splanchnic bed.Br J Pharmacol. 1992 Apr;105(4):1009-13. doi: 10.1111/j.1476-5381.1992.tb09093.x. Br J Pharmacol. 1992. PMID: 1504710 Free PMC article.
-
Metformin and Systemic Metabolism.Trends Pharmacol Sci. 2020 Nov;41(11):868-881. doi: 10.1016/j.tips.2020.09.001. Epub 2020 Sep 28. Trends Pharmacol Sci. 2020. PMID: 32994049 Free PMC article. Review.
Cited by
-
The gastrointestinal tract is a major source of the acute metformin-stimulated rise in GDF15.Sci Rep. 2024 Jan 22;14(1):1899. doi: 10.1038/s41598-024-51866-2. Sci Rep. 2024. PMID: 38253650 Free PMC article.
-
Unveiling the potential pleiotropic effects of metformin in treating COVID-19: a comprehensive review.Front Mol Biosci. 2023 Oct 10;10:1260633. doi: 10.3389/fmolb.2023.1260633. eCollection 2023. Front Mol Biosci. 2023. PMID: 37881440 Free PMC article. Review.
-
Metformin acts in the gut and induces gut-liver crosstalk.Proc Natl Acad Sci U S A. 2023 Jan 24;120(4):e2211933120. doi: 10.1073/pnas.2211933120. Epub 2023 Jan 19. Proc Natl Acad Sci U S A. 2023. PMID: 36656866 Free PMC article.
-
Development of minimally invasive 13C-glucose breath test to examine different exogenous carbohydrate sources in patients with glycogen storage disease type Ia.Mol Genet Metab Rep. 2022 May 11;31:100880. doi: 10.1016/j.ymgmr.2022.100880. eCollection 2022 Jun. Mol Genet Metab Rep. 2022. PMID: 35585965 Free PMC article.
-
Metformin action in the gut-insight provided by [18F]FDG PET imaging.Diabetol Int. 2021 Sep 23;13(1):35-40. doi: 10.1007/s13340-021-00545-y. eCollection 2022 Jan. Diabetol Int. 2021. PMID: 35059241 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical